Sales Revenue Determinants for Generic Pharmaceutical Companies
11 Pages Posted: 26 Sep 2011
Date Written: September 26, 2011
Abstract
We analyze several parameters that influence the amount of sales revenue in generic pharmaceutical companies in Indonesia. The parameters were firms’ one-year lagged of total new products (t-1), one-year lagged profitability (t-1), and market share of new products. Annual data of six large generic pharmaceutical companies were included in the model for a time period spanned from 2003 to 2010. The regression analysis method uses fixed effect models, with generalized least squares (GLS) method. The result shows that firms’ one-year lagged of total new product (t-1), one-year lagged profitability (t-1), and market share of new products to be positive and affect significantly the firms’ sales revenue in the pharmaceutical generic companies in Indonesia.
Keywords: profitability, sales revenue, market share, new generic product, pharmaceutical generic companies
JEL Classification: A10, C23, G30, L21, M21
Suggested Citation: Suggested Citation
Do you have negative results from your research you’d like to share?
Recommended Papers
-
Higher Prices from Entry: Pricing of Brand-Name Drugs
By Jeffrey M. Perloff, Valerie Y. Suslow, ...
-
By Ernst R. Berndt, Linda Tm Bui, ...
-
Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs
By Ernst R. Berndt, Robert S. Pindyck, ...
-
Generic Drug Industry Dynamics
By David Reiffen and Michael R. Ward
-
Hedonic Analysis of Arthritis Drugs
By Iain M. Cockburn and Aslam H. Anis
-
Longer Patents for Increased Generic Competition: The Waxman-Hatch Act after One Decade
By Henry G. Grabowski and John M. Vernon